Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical and Radiographic Analysis of ProDisc-C Vivo to Treat Degenerative Disc Disease: A 7-year Follow-up, Multi-center, Prospective, Randomized, Controlled Clinical Trial.

NCT03367039 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT03367039
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03367039 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical and Radiographic Analysis of ProDisc-C Vivo to Treat Degenerative Disc Disease: A 7-year Follow-up, Multi-center, Prospective, Randomized, Controlled Clinical Trial.
Lead sponsor
Peking University People's Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 1, 2018
Completion date
March 1, 2025
Enrollment
648 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cervical disc disease, disk degeneration